American States Water Company vs Canopy Growth Corp — how do they compare? American States Water Company trades at $84.92 (market cap $3.33B), while Canopy Growth Corp trades at $0.98 (market cap $398.46M). The key difference: American States Water Company is far larger — about 8.4× Canopy Growth Corp's market cap, and American States Water Company pays a 2.37% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| AWR | CGC | |
|---|---|---|
Market Cap | $3.33B | $398.46M |
Sector | Utilities | Health |
52-Week High | $85.05 | $1.92 |
52-Week Low | $70.10 | $0.86 |
Enterprise Value | $4.24B | $337.90M |
Dividend Yield | 2.37% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Trailing returns across standard periods
American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.
Read more on AWR →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →